Clincosm LogoSign in Get a demo

melanoma

Showing NaN - NaN of 113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)

Recruiting
  • Advanced Cancer
  • +7 more
  • Scottsdale, Arizona
  • +14 more
Sep 15, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Melanoma Trial in Worldwide (Pembrolizumab, Pembrolizumab/Quavonlimab, Lenvatinib)

Recruiting
  • Melanoma
  • Pembrolizumab
  • +2 more
  • Los Angeles, California
  • +28 more
Aug 12, 2022

Melanoma, Unresectable Melanoma Trial in Los Angeles, Boston, New York (Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab)

Not yet recruiting
  • Melanoma
  • Unresectable Melanoma
  • Los Angeles, California
  • +3 more
Aug 4, 2022

Melanoma Trial in United States (CMP-001, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Phoenix, Arizona
  • +12 more
Aug 1, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
Aug 1, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +19 more
Aug 1, 2022

Melanoma, Solid Tumor Trial in Korea, Republic of, Spain, United States (DAY101, Pimasertib Hydrochloride)

Recruiting
  • Melanoma
  • Solid Tumor
  • Los Angeles, California
  • +13 more
Jul 27, 2022

Melanoma Trial in Worldwide (Encorafenib, Binimetinib, Pembrolizumab)

Recruiting
  • Melanoma
  • Tucson, Arizona
  • +112 more
Jul 26, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Gilbert, Arizona
  • +4 more
Jun 21, 2022

Advanced Solid Tumor, NSCLC, Melanoma Trial in United States (AB308, Zimberelimab)

Recruiting
  • Advanced Solid Tumor
  • +9 more
  • Phoenix, Arizona
  • +20 more
May 2, 2022

Melanoma, Non Small Cell Lung Cancer Trial in United States (VV1, Cemiplimab, Ipilumumab)

Recruiting
  • Melanoma
  • Non Small Cell Lung Cancer
  • VV1
  • +2 more
  • Phoenix, Arizona
  • +22 more
Apr 21, 2022

Melanoma Trial in Los Angeles, Boston, New York (Ipilimumab, Nivolumab, Tocilizumab)

Recruiting
  • Melanoma
  • Los Angeles, California
  • +3 more
Mar 29, 2022

NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • N-803 + Pembrolizumab
  • +9 more
  • Anchorage, Alaska
  • +34 more
Apr 4, 2022

Melanoma Trial in Worldwide (Relatlimab, Nivolumab)

Active, not recruiting
Has Results
  • Melanoma
  • Relatlimab
  • Nivolumab
  • Tucson, Arizona
  • +126 more
Mar 2, 2022

Melanoma Trial in Australia, United States (PV-10, Pembrolizumab)

Recruiting
  • Melanoma
  • Los Angeles, California
  • +6 more
Mar 22, 2022

Melanoma, Carcinoma, Non-Small- Cell Lung Trial in Worldwide (SEA-CD40, pembrolizumab, pemetrexed)

Recruiting
  • Melanoma
  • Carcinoma, Non-Small- Cell Lung
  • Springdale, Arkansas
  • +18 more
Mar 11, 2022

Melanoma Trial in France, Germany, United States (Talimogene laherparepvec, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Tucson, Arizona
  • +39 more
Mar 9, 2022

Melanoma Trial in United States (MGA271)

Terminated
  • Melanoma
  • MGA271
  • Los Angeles, California
  • +6 more
Feb 4, 2022

Melanoma, Non Small Cell Lung Cancer Trial in United States (enoblituzumab plus ipilimumab)

Completed
  • Melanoma
  • Non Small Cell Lung Cancer
  • enoblituzumab plus ipilimumab
  • Los Angeles, California
  • +9 more
Feb 4, 2022

Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

Completed
  • Prostate Cancer
  • +6 more
  • MGA271
  • Los Angeles, California
  • +11 more
Feb 4, 2022